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The purpose of this study is to identify trends in participation, clinician performance,
program scores, and payment adjustments received for rural and urban providers during the
MIPS 2018 Performance Year. Five contiguous states in the southeastern US were selected for
this study due to their significant rural population: Alabama, Georgia, South Carolina, North
Carolina, and Tennessee. Descriptive statistics were used to summarize participation and
performance data for rural and urban providers in the Southeastern US, as reported in the 2018
QPP Experience Report Public Use File and made publically available by CMS. The study
findings extend prior evidence that has shown that value-based payment programs
disproportionately penalize rural healthcare providers when compared to their urban counterparts
(Johnston, 2020; Khuller, 2020; Navathe, 2019). It will be vital for CMS to identify and
appropriately address barriers to participation and performance faced by rural healthcare
providers to ensure the success of the MIPS program.
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CHAPTER I INTRODUCTION
1.1 Background and Need
Historically, payment systems for reimbursing physicians in the outpatient setting were
based on a fee-for-service model, where physicians were financially incentivized for volume of
services provided over value, cost-effectiveness, or patient outcomes. Prior to 2015, the Centers
for Medicare and Medicaid Services (CMS) calculated physician payment rates for Medicare
through an algorithm based on the relative value of a physician’s work, a modifier to adjust for
geographic differences, and a monetary conversion factor known as sustainable growth rate
(SGR) (CMS, 2015; Ryan, 2015). This formula was intended to ensure Medicare expenditures
did not exceed growth in the national economy. By setting target expenditures relative to gross
domestic product (GDP), annual adjustments would be made to the physician fee schedule if
physician spending exceeded or was less than the calculated targets.
During the initial years of the SGR formula used to set physician fee schedules,
physicians saw modest payment increases. However, with the economic downturn that occurred
starting in 2001, SGR targets were lowered and physician spending continued to rise (Ryan,
2015). Actual expenditures exceeded allowed targets, and a statutory 4.8% physician payment
cut across the board was triggered in 2002 (Fontenot et al., 2015). The significant payment cut
resulted in fury from physicians, hospitals, and medical trade associations. The medical
community reacted to the payment adjustment and claimed their ability to care for Medicare
beneficiaries would be drastically jeopardized (Carey, 2013). In the following years, physician
spending continued to increase beyond GDP year-over-year (Aizenman, 2010). The increase in
spending over the allowed targets should have triggered negative adjustments to the Medicare
fee schedule, resulting in additional payment cuts for physicians to control federal spending.
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However, instead of implementing physician cuts as the SGR mandated, pressure from the
provider community and a lobbying blitz resulted in the passing of short-term congressional
patches, or “doc fixes”, to delay payment adjustments from 2003 through 2014 (Hahn, 2014).
Several proposals to overhaul the Medicare physician payment system permanently were
introduced throughout these years; however, Congress was unsuccessful in passing legislation to
repeal SGR, minimize disruption to the Medicare program, and sustainably reduce federal
spending long-term. This congressional failure to pass legislation was mostly due to bipartisan
disagreement on how to finance a repeal of the SGR and overall budget implications for federal
spending (Hedstrom, 2014).
When the last congressional patch delaying payment adjustments expired on March 31,
2015, the healthcare industry would have faced a 21.2% payment reduction to physician payment
rates across the board (Fontenot et al., 2015). This would have significantly destabilized the
Medicare system and resulted in physicians unable or unwilling to participate in the program or
limiting the number of beneficiaries they can provide service to and remain financially viable.
The resulting impact on patient access to care would have significant implications for the entire
health care system. It was apparent to the industry that physician payments could not sustainably
be determined with a fee-for-service model that incentivized the volume of services delivered
with no regard to value or quality.
After the 2104 midterm elections and subsequent changes to congressional committees,
lawmakers resurrected the effort to repeal SGR as a key topic in the 114th Congress. The
Medicare Access and CHIP Reauthorization Act (MACRA) was introduced in the House of
Representatives on March 24, 2015, passed with a vote of 392 to 37, and was sent to the Senate
for voting on March 26, 2015. On April 14, 2015, the bill passed the Senate with a vote of 92 to
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8 and was presented to President Barack Obama. Within two days, President Obama signed the
bill, and MACRA went into effect as public law on April 16, 2015 (Congress.gov, 2015). In a
rare demonstration of successful bipartisanship and bicameral negotiations, MACRA was passed
within a 3-week period.
MACRA overhauls the method for calculating physician and other healthcare provider
reimbursement under the Medicare program. This law created the Quality Payment Program
(QPP), which repealed the SGR, established a new payment system for provider reimbursement,
and created financial incentives for providers to participate in value-based care (CMS, 2019a).
Beginning in 2017, eligible clinicians are required to participate in one of two program tracks
each year under QPP: the Merit Based Incentive Program (MIPS) or Advanced Alternative
Payment Models (APMs). Clinicians receive positive or negative performance-based payment
adjustments to their Medicare Part B fee schedule by reporting clinical, financial, and
administrative data each year. Clinicians required to participate in QPP must satisfy the
requirements of one of these two tracks to avoid negative payment adjustments in subsequent
years. MIPS builds on the existing fee-for-service payment model and modifies it to incentivize
value and outcome-driven, quality care, and discourages the overutilization of services.
Advanced APMs are risk-based models that reward groups of clinicians for delivering costeffective care and engaging in care-coordination. Advanced APMs give clinicians a higher
financial incentive to completely move away from the modified fee-for-service model, and are
encouraged to rely on care coordination, cost-effective practices and data sharing to treat patients
(CMS, 2019a).
Clinicians participating on the MIPS track receive performance-based payment
adjustments by reporting data on four weighted categories: Quality, Cost, Promoting
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Interoperability, and Improvement Activities. For the 2018 program year, the Quality category
was weighted at 50%, the Promoting Interoperability category was weighted at 25%, the
Improvement Activities category was weighted at 15%, and the Cost category was weighted at
10%. Individual scores from each of these categories were combined to calculate a composite
performance score for each provider or provider group, ranging from 0 to 100 points. Composite
MIPS scores based on 2018 performance data is compared against threshold scores calculated by
CMS by geographic region, and used to adjust reimbursed payment in 2020 (Squitieri & Chung,
2017).
Based on historical benchmarks for measures and the 2018 performance data, CMS
determined the following thresholds for receiving payment adjustments: 0-14 points is a negative
payment adjustment up to -5%, 15-69 points is between earning no payment adjust to a modest
positive payment adjustment up to 5%, and 70-100 is “exceptional performance” where
clinicians are eligible to receive an additional positive payment adjustment. CMS determines
these thresholds and the amount of the scaled payment adjustments received by clinicians to be
budget-neutral, with an additional $500,000,000 to be distributed to exceptional performers
(Squitieri & Chung, 2017). There are also many special scoring mechanisms, like bonus points,
reweighting of categories, exemptions, and special status designations that may allow providers
to earn more points and higher payment adjustments or be excluded from participation from
MIPS. Individual providers and groups were excluded from participating in MIPS for the 2018
performance year if they billed less than or equal to $90,000 in Medicare Part B allowable
charges or had fewer than 200 Medicare Part B beneficiaries the prior year (CMS, 2021b).
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1.2 Problem Statement
MACRA was ultimately passed to control long-term federal spending on healthcare. The
United States continues to spend a significant amount on healthcare annually, with the federal
government sharing a large portion of the total healthcare expenditures. In 2019, the US spent a
total of $3.8 trillion on healthcare expenditures, accounting for 17.7% of the nation’s GDP
(CMS, 2019b). Roughly 21% of total healthcare expenditures in 2019, or $800 billion, was
directly related to the Medicare program (CMS, 2019b). Over the last decade, federal spending
on Medicare in the form of benefit payments has grown continuously (Cubanski, 2018).
Medicare spending is projected to continue growing at an average rate of 7.6% over the next
several years, faster than any other major payer in healthcare (Keehan et al., 2020). This
projected growth in spending can be attributed primarily to increased enrollment of Medicare
beneficiaries, volume of services, and healthcare prices (Cubanski, 2018). Medicare plays a
major role in the American healthcare system with the significant amount of federal dollars that
are spent and the large number of beneficiaries.
Historical attempts at a sustainable physician payment system for Medicare have largely
failed to reduce federal spending, stabilize health care costs, or encourage healthcare providers to
deliver high quality, value-based care. Due to the congressional patches delaying payment cuts,
the SGR method failed to ensure that federal healthcare expenditures did not exceed growth in
the national economy. Legacy CMS programs like the Physician Quality Reporting Program
(PQRS), Value-based Payment Modifier (VM), and Medicare Electronic Health Record
Incentive Program/Meaningful Use (MU) were also unsuccessful in reducing overall federal
spending on Medicare. This failure can be attributed to several factors (MedPAC, 2018):
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● A lack of universal participation from providers resulting from voluntary reporting
requirements
● Single-sided financial risk models incentivized participation, but did not discourage
nonparticipation
● Insignificant financial penalties for not participating in value-based care
● Programs relied on the existing fee-for-service model, which does not control utilization
of services
● Cumbersome reporting and technical requirements discouraged provider participation in
quality programs
● Quality performance data on providers was not publicly available.
CMS attempted to address these historical failures by consolidating PQRS, VM, and MU
into a single, streamlined, mandatory reporting program under MIPS. CMS has taken
incremental steps toward modifying the program since its implementation in 2017, and continues
to “further refine program requirements, respond to stakeholder feedback, reduce reporting
burden, encourage meaningful participation, and improve patient outcomes” (CMS, 2021b, p. 1).
The implementation of QPP represents a monumental shift in the industry toward reimbursing
healthcare providers for value over volume and eliminating the historical fee-for-service model.
In addition to this qualitative approach to improvement, it is vital to the success of the program
for CMS to consider the quantitative data collected in future program modifications.
Rural healthcare providers have historically been disadvantaged when faced with valuebased care and participation in quality reporting programs. They face structural barriers,
practitioner shortages, hospital closures, and healthcare disparities that present challenges to
achieving equitable outcomes in treating rural populations (Graves & Hammarlund, 2020). Small
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and rural hospitals also have less experience with value-based purchasing models and reporting
programs (LaPointe, 2017). To account for the barriers faced by rural providers, CMS created
eligibility exemptions and special scoring mechanisms under QPP to encourage participation and
mitigate the effect of low program performance. CMS developed low-volume thresholds to
exclude providers in small and rural hospitals that did not have enough Medicare revenue and
patients to significantly take part in MIPS. In addition to the low-volume threshold, CMS also
exempts most providers who are practicing in a rural health clinic or critical access hospital from
participating in MIPS (LaPointe, 2017). For rural providers that are not exempt from MIPS,
CMS automatically awards double the points for each improvement activity submitted (CMS,
2021c).
1.3 Research Questions
This study examines MIPS program data from the 2018 Performance Year [January 01,
2018 to December 31, 2018], made publicly available by CMS. The aim of the study is to
identify trends in MIPS participation, clinician performance, program category scores, reported
quality measures, payment adjustments and submission methods across rural clinicians
practicing in Alabama, Georgia, South Carolina, North Carolina, and Tennessee. This analysis is
intended to provide CMS with key data-driven trends and statistics to incorporate into the
continuing effort to improve MIPS and QPP, as well as ensure rural providers can participate and
succeed under the program. This retrospective descriptive study explores MIPS program data
and identifies useful trends and statistics for rural healthcare stakeholders. The following
research questions were examined for Southeastern rural providers and compared with their
urban counterparts:
●

What was the participation rate for eligible providers in the 2018 Performance Year?
14

●

Did most providers report as individuals, groups, or participate in a MIPS APM?

●

What final and category scores did eligible providers receive?

●

How did eligible providers perform against the CMS-established benchmarks?

●

Which percentage of providers received positive, negative, or neutral payment
adjustments?

1.4 Population
The population included in this study are eligible clinicians from the 2018 Performance
Year of MIPS. CMS defines eligible clinicians as the following licensed healthcare providers:
physicians (including doctors of medicine, doctors of osteopathy, osteopathic practitioners,
doctors of dental surgery, doctors of dental medicine, doctors of podiatric medicine, doctors of
optometry, and chiropractors), physician assistants, nurse practitioners, clinical nurse specialists,
and certified registered nurse anesthetists. MIPS participation exemptions were given to eligible
clinicians based on the following criteria: clinicians enrolling in the Medicare program for the
first time in 2018, participation in an Advanced APM, less than $90,000 billed in physician fee
schedule services furnished to Medicare fee-for-service (FFS) beneficiaries, or clinicians who
have 200 or fewer Medicare Part B FFS beneficiaries (CMS, 2018). A total of 889,995 eligible
clinicians were included in the 2018 MIPS Performance Year (Verma, 2020).
This study specifically examines eligible clinicians who received a rural designation
during the 2018 MIPS Performance Year. CMS designates an individual practitioner as rural if
the clinician is associated with a practice located in a rural-designated zip code, as defined by the
Federal Office of Rural Health Policy. Data from five contiguous southeastern US states
(Alabama, Georgia, South Carolina, North Carolina, and Tennessee) were selected for analysis,
due to their significant rural populations as a region.
15

CHAPTER II SCOPING LITERATURE REVIEW
2.1 Introduction
A review of the literature was performed using the PubMed Library Database. Research
published between 2017 to 2021 were considered in this literature review, which aligns with the
time frame from the first performance year following MIPS implementation to present day.
There are few published studies of the overall impact of MIPS on the healthcare system to date,
likely due to the program being in the early years of its implementation. Additionally, CMS
implemented flexibilities in data submission deadlines, payment adjustments, and participation
requirements for MIPS in response to the 2019 Novel Coronavirus (COVID-19) pandemic
(CMS, 2021a). Furthermore, limited research has been conducted on rural healthcare and
participation in or performance under QPP or MIPS at the time of this study. This literature
review focuses on the available research surrounding MIPS to date, which was found to be
largely related to early concerns and criticism of MIPS received from the healthcare industry and
lessons learned from the MIPS 2017 Performance Year.
2.2 Program Design
Most of the available literature on MIPS is focused on the program’s design, particularly
on the scoring methodology and payment incentives. An area of uncertainty cited in the literature
is how clinicians will respond to the MIPS incentive design and the program's ability to achieve
its long-term goals (Nuckols, 2017). The relationship between the design of the program, its payfor-performance incentives, and the effectiveness of MIPS has not been empirically examined
because the program is only in its fifth year of implementation. One study published during the
first year of the program anticipated the payment incentives for clinicians were too “weak” to
reduce the provision of services, or that some features of MIPS created incentives to do more
16

rather than less (McWilliams, 2017). Research published in the years following mimicked this
concern that the program design resulted in low payment incentives received by clinicians, which
were validated by early MIPS program data. In a 2019 study published in Health Affairs,
researchers found that the maximum positive MIPS payment adjustment for participants in 2017
was only 1.88%, an amount lower than the plus 4% to 22% increase publicized by CMS
(Navathe et al., 2019). A 2020 study published in Health Affairs similarly criticized CMS’
decision to implement MIPS with such low performance thresholds, concluding that the decision
resulted in a low marginal benefit of participation in the program and limited incentives to
incrementally improve provider performance (Apathy, 2020).
In addition to early criticisms of the payment incentives under MIPS, existing literature
focuses on the scoring methodology under the program. A 2019 study published in the Journal of
the American Medical Association claimed the limited number of measures and allowance of
choice for which measures to report makes it “difficult to believe the MIPS will have a
meaningful impact on patient outcomes or experiences” (Rathi, 2019). Another study similarly
criticized the program’s scoring methodology, which grades clinicians on a curve and results in
providers with identical performance measures receiving different scores (McWilliams, 2017).
2.3 Program Participation
In the 2018 QPP Reporting Experience Report published by CMS, a total of 889,995
clinicians were determined to be eligible for participation in MIPS for the 2018 Performance
Year. Of all eligible clinicians, 874,515, or 98%, participated in the program (QPP, 2020). In the
2017 QPP Reporting Experience Report, a total of 1,057,824 clinicians were eligible for MIPS in
2017, with 1,006,319, or 95% participating (QPP, 2019). Fewer clinicians were considered
eligible for participation in MIPS in 2018 due to changes in the low-volume thresholds, which
17

exempted certain clinicians from participation in MIPS. This was intentionally designed by CMS
to allow for providers and the healthcare industry more time to be familiar with the program
before participating. CMS established a goal of having 90% of MIPS eligible clinicians
participate in the program, which was exceeded in the first year of the program (QPP, 2019).
Although CMS reported high overall participation rates in the first two years of the MIPS
program, a 2020 study published in Health Affairs, raised concerns of the actual participation in
the program. In contrast to the 98% overall participation rate in 2017, assessing clinician
participation in individual MIPS categories indicated substantially lower participation rates. The
study showed 26.5% of clinicians did not participate in the Quality category, 16.9% of clinicians
did not participate in the Improvement Activities category, and 34.8% of clinicians did not
participate in the Advancing Care Information category in 2017 (renamed to Promoting
Interoperability category in 2018 (Apathy & Everson, 2020). With almost half of participating
clinicians not participating in all three MIPS categories for 2017, the study authors advised
caution when claiming the 95% participation rate indicated program success (Apathy & Everson,
2020).
A 2019 study published in the Journal of the American Medical Association reiterated the
concern of inflated participation rates and the implications for measuring program success. The
study authors argued that the extreme flexibility in measure selection and data submission,
combined with the low scoring thresholds set by CMS, allowed clinicians to submit minimal data
lacking clinical validity and still count as participating in the program (Rathi & McWilliams,
2019).
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2.4 Participation Type
In the 2018 QPP Reporting Experience Report published by CMS, 53% of clinicians
reported as a group, 41% participated in a MIPS APM, and 6% reported as individuals (QPP,
2020). In the 2017 QPP Reporting Experience Report, 54% of clinicians reported as a group,
34% participated in a MIPS APM, and 12% reported as individuals (QPP, 2019). CMS also
introduced an additional method of participating in 2018, referred to as virtual groups; however,
no clinicians reported under this participation type in 2018 (QPP, 2020). The data from the first
two years of MIPS indicated clinicians are more often reporting as a group, and moving away
from individual reporting. This data also showed the significant participation in MIPS through
APMs indicates that “clinicians and practices are interested in and moving toward value-based
arrangements and taking on additional risk for the outcomes of their patients” (QPP, 2019, p.9).
2.5 Payment Adjustments
Prior to releasing the full results and performance data for the 2018 MIPS Performance
Year, CMS published preliminary results highlighting provider participation and payment
adjustments received. CMS claimed 98% of eligible clinicians participating in MIPS received a
positive payment adjustment, which is an increase from the 93% of eligible clinicians who
received a positive payment adjustment in the 2017 MIPS Performance Year (Verma, 2020).
CMS also claimed 97% of eligible clinicians in rural practices received a positive payment
adjustment, compared to 93% in 2017. CMS concluded that the high participation rates among
rural and small providers supported their efforts in “making strides towards making MIPS a
practical program for every clinician, regardless of size” (Verma, 2020).
Similar to the concerns of inflated overall participation rates, the 2020 Health Affairs
study also raised concerns of the percentage of clinicians receiving a positive payment
19

adjustment without participating in all MIPS categories. The study found that 74% of clinicians
who only partially participated in the program received positive payment adjustments in the 2017
MIPS Performance Year (Apathy & Everson, 2020). Thus, although CMS reported 93% of
clinicians received a positive payment adjustment in 2017, only 19% of clinicians participated in
all MIPS categories and avoided a negative payment adjustment (QPP, 2019).
2.6 Rural Practices
At the time of this study, no published study had examined rural providers and their
participation and performance during the first two years of the MIPS program. One study,
however, examined performance based payment adjustments for small and rural providers versus
all eligible providers across the US. In that analysis of 2017 MIPS performance data posted in
Health Affairs Blog, “larger and non-rural practices performed considerably better than their
smaller and rural counterparts” (Navathe et al., 2019, p. 1).
Figure . 2017 MIPS Payment Adjustments By Practice Size (Navathe et al., 2019)

As shown in Figure 1, the analysis by Navathe and colleagues revealed that fewer rural practices
qualified as exceptional performers, as defined by CMS as having a final MIPS score of 70 or
greater The researchers’ analysis also showed that, on average, rural practices performed worse
20

than large practices, as evidenced by a median final MIPS score of 75.29 for rural practices
versus 90.29 for large practices in 2017 (Navathe et al., 2019).
Rural practices are often associated with serving patients who face greater health
disparities and are more socially disadvantaged and socially at-risk than urban patients. (RHI,
2019). In a study published in the Journal of the American Medical Association, Kullar et al.
(2020) determined that providers with the highest proportion of socially disadvantaged patients
had significantly lower MIPS scores. This cross-sectional study found physicians working at
safety net practices scored lower across all MIPS categories in 2017. In a study published in
Health Affairs, Johnston et al. found that clinicians with the highest socially at-risk caseloads
scored 13.4 points lower in their final MIPS score than clinicians with the lowest socially at-risk
caseload (2020). Additionally, the study found clinicians with the highest socially at-risk
caseloads “were 99 percent more likely to receive a negative payment adjustment, and were 52
percent less likely to receive an exceptional performance bonus payment” (Johnston et al., 2020).
2.7 Conclusion
Available research on the impact of MIPS and its viability as a permanent physician
payment system is mostly based on qualitative data and conjecture from historical experiences;
Few studies to date empirically evaluated or utilized quantitative data in rural providers and
practices. Although the high overall participation rates in the first two years of the MIPS
program are laudable, participation in individual categories is substantially lower.
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CHAPTER III METHODOLOGY
3.1 Research Design and Data Set Description
This retrospective descriptive cohort analysis identifies and describes trends in the MIPS
2018 Performance Year. This study can help CMS continue to improve the design of QPP and
shape the reporting requirements and scoring methodology for rural providers participating in
MIPS. This study can also help other healthcare quality stakeholders, including rural healthcare
providers, identify key trends and program factors that may affect rural provider participation in
MIPS, and consequently their Medicare reimbursement. This descriptive study uses publicly
available MIPS data from 2018 to identify trends in program performance for rural providers
versus their urban counterparts in the following Southeastern states: Alabama, Georgia, South
Carolina, North Carolina, and Tennessee. No hypothesis was tested as part of this study.
CMS released the 2018 QPP Experience Report Public Use File (PUF) on October 28,
2020. The file, available on CMS’ public data website (data.cms.gov), allows users to view data
regarding MIPS participation and performance during the 2018 performance year. The
information provided in the PUF covers eligibility and participation, performance categories, and
final score and payment adjustments for individual providers, identified by their respective
National Provider Identifier [NPI]. Per CMS rules, information on NPIs with fewer than 11
beneficiaries are suppressed from public use on the PUF (HealthCentric Advisors, 2020).
3.2 Variable Description
The PUF dataset includes all healthcare providers deemed eligible for participation in
MIPS during the 2018 Performance Year. All healthcare providers that billed more than $90,000
in Medicare Part B claims, or had more than 200 Medicare Part B beneficiaries during CMS’
eligibility determination period, were included in the PUF whether they submitted data or not.
22

Five contiguous states in the southeastern US were selected for this study, due to their
significant rural populations as a region: Alabama, Georgia, South Carolina, North Carolina, and
Tennessee. The PUF identifies the practice state as the location of the provider’s billing address
where services are rendered. Within the selected Southeastern US states, providers fall into one
of two categories: rural or urban. If applicable, providers are directly indicated as “rural” on the
PUF. CMS designates an individual practitioner as rural if the clinician is associated with a
practice located in a rural-designated zip code, as defined by the Federal Office of Rural Health
Policy. For this analysis, all providers not designated as rural on the PUF were considered urban
providers.
This study assessed the following outcomes related to participation and performance in
MIPS, included as variables on the PUF (CMS, 2020):
● Participated: indicates if the clinician reported data or received a Final Score greater than
zero
● Participation Type: indicates the reporting method from which the clinician received a
final score; in 2018, clinicians had the option of reporting for MIPS as a group,
individually, or by participating in a MIPS APM
● Final Score: the overall score (on a numerical scale of 0 to 100) received by the eligible
clinician for the performance year; also referred to as the Composite Performance Score
(CPS)
● Quality Category Score: the unweighted score received by the participant for the Quality
score that is used for the overall score
● Promoting Interoperability (PI) Category Score: the unweighted score received by the
participant for the PI category that is used for the final score
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● Improvement Activity (IA) Category Score: the score received for the IA category based
on all the IA measures picked and IA bonuses received for the category that contributed
to the final score
● Cost Score: the unweighted score received for the Cost category based on all the cost
measures reported and used for final scoring
● Payment Adjustment: the payment adjustment received by comparing the overall score
obtained by the eligible clinician to the performance thresholds.
3.3 Data Analysis
Descriptive statistics were used to summarize participation and performance data for
rural and urban providers in the Southeastern US. Counts and percentages were used to describe
program participation, participation type, performance based on CMS-publicized thresholds on
scores and payment adjustments. Averages were used to evaluate final scores, category scores,
and payment adjustments. The chi-square test was used to determine if descriptive statistics for
categorical variables differed by rural vs urban designation. The categorical variables in this
study included participation (true or false) and participation type (group, individual, or MIPS
APM). T-tests were used to determine if descriptive statistics for continuous variables differed
by rural vs urban designation. The continuous variables in this study included the final score,
category scores, and payment adjustment.
3.4 Protection of Human Subjects
The use of this data set is unrestricted and made publicly available by CMS. It does not
contain healthcare restricted or patient information. Therefore, Institutional Review Board
approval was not needed.
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CHAPTER IV RESULTS
4.1 Results/Findings
The objective of the study was to identify trends in MIPS participation and performance
among rural and urban providers in select Southeastern states for the 2018 Performance Year.
Using MIPS program data made publicly available by CMS, the following research questions
were examined for Southeastern rural providers and compared with their urban counterparts:
•

What was the participation rate for eligible providers in the 2018 Performance Year?

•

Did most providers report as individuals, groups, or participate in a MIPS APM?

•

Which final and category scores did eligible providers receive?

•

How did eligible providers perform against the CMS-established benchmarks?

•

Which percentage of providers received positive, negative, or neutral payment
adjustments?
A total of 882,493 providers across the US were designated by CMS as eligible clinicians

for the 2018 MIPS Performance Year. Of those 882,493 providers, 115,826, or approximately
13%, were designated as rural, and 766,667 providers, or approximately 87%, were considered
as practicing in urban areas. Of the total 882,493 eligible clinicians in the US, 108,112 (12.3%)
providers were located in the five selected Southeastern states for this study: Alabama, Georgia,
South Carolina, North Carolina, and Tennessee. Of those 108,112 providers, 19,202, or
approximately 18%, were designated by CMS as rural, and the remaining 88,910, or
approximately 82%, were considered to be practicing in urban areas.
4.1.1 Findings in MIPS Participation
As shown in Table 1, a total of 992,493 providers were eligible for MIPS in 2018 across
the US. Of those providers 867,018, or 98.25%, participated in the program and 15,475, or
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1.75%, did not participate in MIPS. Of the rural providers eligible for MIPS nationally, 113,809,
or 98.26%, participated in the program, while 2,017, or 1.74%, did not participate. Of the urban
providers eligible for MIPS nationally, 753,209, or 98.24%, participated in the program, while
13,458, or 1.76%, did not participate. Participation rates between rural and urban providers
nationally was not statistically significantly different (P=0.735).
Table 1 also expresses the participation rates for providers in the selected Southeastern
states for this study. A total of 108,112 providers in the selected Southeastern states were eligible
for MIPS in 2018. Of those providers, 106,989, or 98.96%, participated in the program, and
1,123, or 1.04%, did not participate in MIPS. Of the rural providers eligible for MIPS in the
Southeast, 18,946, or 98.67%, participated in the program, while 256, or 1.33%, did not
participate. Of the urban providers eligible for MIPS in the Southeast, 88,043, or 99.02%,
participated in the program, while 867, or 0.98%, did not participate. The difference in
participation rates between rural and urban providers in the Southeast was statistically
significantly lower among rural providers by 0.35% (P<0.001).
Table . MIPS Participation Rates

All Providers
(n=882,493)
n (%)
Participated
Did Not Participate

Nationally
Rural Providers
(n=115,826)
n (%)

867,018 (98.25)

113,809 (98.26)

753,209 (98.24)

15,475 (1.75)

2,017 (1.74)

13,458 (1.76)

Southeastern US
All Providers
Rural Providers
(n=108,112)
(n=19,202)
n (%)
n (%)
Participated
Did Not Participate

Urban Providers
(n=766,667)
n (%)

Urban Providers
(n=88,910)
n (%)

106,989 (98.96)

18,946 (98.67)

88,043 (99.02)

1,123 (1.04)

256 (1.33)

867 (0.98)
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P-Value
0.735

P-Value
< 0.001

4.1.2 Findings in MIPS Participation Type
As shown in Table 2, 466,909, or 53.85% of providers in the US participated in MIPS as
a group, 348,893, 40.24%, participated through a MIPS APM, and 51,216, or 5.91%, participated
as individuals. Of the rural providers who participated in MIPS across the US, 59,693, or
52.45%, participated as a group, 46,048, or 40.46%, participated through a MIPS APM, and
8,086, or 7.09%, participated as individuals. Of the urban providers who participated in MIPS
across the US, 407,216, or 54.06%, participated as a group, 302,845, or 40.21%, participated
through a MIPS APM, and 43,148, or 5.73%, participated as individuals. Rural providers in the
US were 1.36% more likely to participate as individuals than their urban counterparts
(P<0.001).
Table 2 also expresses the distribution of providers by participation type in the selected
Southeastern states for this study. A total of 46,068 providers, or 43.06%, in the Southeast
participated in MIPS as a group, 53,919, or 50.40%, participated through a MIPS APM, and
7,002, or 6.54%, participated as individuals. Of the rural providers who participated in MIPS in
the Southeast, 8,804, or 46.47%, participated as a group, 8,207, or 43.32%, participated through
a MIPS APM, and 1,1935, or 10.21%, participated as individuals. Of the urban providers who
participated in MIPS in the Southeast, 37,264, or 42.32%, participated as a group, 45,712, or
51.92%, participated through a MIPS APM, and 5,067, or 5.76%, participated as individuals.
The difference in individual participation among Southeastern rural and urban providers were
more pronounced than in the US, with rural Southeastern providers participating as individuals at
almost double the rate of their urban counterparts (rate difference 4.45%; P<0.001).
While a higher percentage of rural and urban providers participated in MIPS as a group
nationally, a higher percentage of urban providers participated through a MIPS APM rather than
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through a group or individually in the Southeast. Additionally, a higher percentage of rural
providers in the Southeast participated in MIPS as individuals versus their urban counterparts
and rural providers nationally.
Table . MIPS Participation Type

All Providers
(n=867,018)
n (%)
Group
Individual
MIPS APM

Nationally
Rural Providers Urban Providers
(n=113,809)
(n=753,209)
n (%)
n (%)

466,909 (53.85)

59,693 (52.45)

407,216 (54.06)

51,216 (5.91)

8,068 (7.09)

43,148 (5.73)

348,893 (40.24)

46,048 (40.46)

302,845 (40.21)

Southeastern US
All Providers
Rural Providers Urban Providers
(n=106,989)
(n=18,946)
(n=88,043)
n (%)
n (%)
n (%)
Group
Individual
MIPS APM

46,068 (43.06)

8,804 (46.47)

37,264 (42.32)

7,002 (6.54)

1,935 (10.21)

5,067 (5.76)

53,919 (50.40)

8,207 (43.32)

45,712 (51.92)

P-Value

< 0.001

P-Value

< 0.001

4.1.3 Findings in MIPS Final and Category Scores
Table 3 expresses the average final scores received for MIPS 2018, as well as the average
scores received in each of the four MIPS categories. CMS scores eligible Medicare Part B
clinicians on a 100-point performance scale which results in a Composite Performance Score
(CPS), or the final score. In this dissertation study, the average scores were determined for all
eligible clinicians across the US, all eligible clinicians in the Southeast, and all participating
providers in the Southeast. Nationally, the mean final score for rural eligible clinicians, 85.96
points, was statistically significantly lower than for urban eligible clinicians, 87.00 points
(P<0.001). The mean final score for rural eligible clinicians in the Southeast was 83.05 points,
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which was statistically significantly lower than the mean final score for their urban counterparts
at 87.94 points (P<0.001). Similarly, when looking only at MIPS participating providers in the
Southeast, rural providers scored statistically significantly lower than urban providers by 4.62
points (P<0.001).
Similar to what was found in overall average scores, the average category scores for rural
providers were statistically significantly lower than urban providers across three MIPS
categories: Quality, Promoting Interoperability, and Improvement Activities (Table 3).
Nationally, rural providers scored an average of 0.95, 3.58, and 0.34 points lower than urban
providers in the Quality, Promoting Interoperability, and Improvement Activities categories,
respectively (P<0.001) (Table 3). In the Southeast, rural providers scored an average of 6.53,
12.45, and 0.86 points lower than urban providers in the Quality, Promoting Interoperability, and
Improvement Activities categories, respectively (P<0.001) (Table 3). Within participating
providers only in the Southeast, rural providers scored an average of 6.32, 12.36, and 0.72 points
lower than urban providers in the Quality, Promoting Interoperability, and Improvement
Activities categories, respectively (P<0.001) (Table 3).
Nationally, for the remaining category cost, rural providers tended to average higher. The
mean score for the cost category for rural eligible clinicians was 0.10 points higher than for
urban eligible clinicians, although this difference was not statistically significant (P=0.447)
(Table 3). In the Southeast, the mean score for the cost category for both rural and urban eligible
clinicians was 27.03. When looking only at MIPS participating providers in the Southeast, the
mean score for the cost category was statistically significantly higher for rural providers than for
urban providers by 4.92 points (P<0.001) (Table 3).
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Table 4 shows the distribution of rural and urban providers and the final scores received,
both nationally and in the Southeast. Across the US, the percentage of rural providers who
received the minimum MIPS score, or 0 points, was lower than the percentage of urban providers
(1.74% and 1.76%, respectively). However, when looking only at Southeastern states, the
percentage of rural providers who received a final score of 0 was higher than the percentage of
urban providers (1.33% and 0.98%, respectively). Both nationally and in the Southeast, the
percentage of providers who received the maximum MIPS score possible, or 100 points, was
lower for rural providers than for urban providers. In the Southeast, while 51.25% of urban
providers received the maximum MIPS score, only 46.80% of rural providers received the same
number of points.
Table 4 also shows the distribution of providers who were categorized as low, high, and
exceptional performers, determined by final score thresholds set by CMS. Both nationally and in
the Southeast, the percentage of rural providers who were low performers, or received a final
score of less than 15 points, was higher when compared with urban providers. Among rural
providers in the Southeast, 2.27% were low performers, while 1.11% of urban providers were in
the same category. Similarly, the percentage of rural providers who qualified as exceptional
performers, or received a final score of above 70 points, was lower than for urban providers.
While 83.17% of urban providers in the Southeast qualified as exceptional providers, 76.45% of
rural providers received scores above 70 points.
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Table . Average MIPS Final and Category Scores

All Providers
(n=882,493)
Mean (SD)

Nationally
Rural Providers
(n=115,826)
Mean (SD)

Urban Providers
(n=766,667)
Mean (SD)

P-Value

Final Score

86.87 (24.00)

85.96 (25.03)

87.00 (23.84)

< 0.001

Quality Category
Score

81.82 (30.20)

80.99 (31.02)

81.94 (30.08)

< 0.001

PI Category Score

70.97 (44.18)

67.86 (45.39)

71.44 (43.98)

< 0.001

IA Category Score

38.12 (8.21)

37.82 (8.83)

38.16 (8.12)

< 0.001

Cost Category
Score

31.97 (39.36)

32.05 (40.63)

31.95 (39.16)

0.447

Urban Providers
(n=88,910)
Mean (SD)

P-Value

Southeastern US
All Providers
Rural Providers
(n=108,112)
(n=19,202)
Mean (SD)
Mean (SD)
Final Score

87.07 (23.71)

83.05 (27.04)

87.94 (22.83)

< 0.001

Quality Category
Score

82.49 (29.63)

77.12 (33.34)

83.65 (28.64)

< 0.001

PI Category Score

70.65 (44.35)

60.41 (47.46)

72.86 (43.32)

< 0.001

IA Category Score

38.12 (8.16)

37.42 (9.52)

38.28 (7.82)

< 0.001

Cost Category
Score

27.90 (39.35)

27.03 (38.71)

27.03 (38.71)

< 0.001

Southeastern US (Participating Providers)
All Providers
Rural Providers Urban Providers
(n=106,989)
(n=18,946)
(n=88,043)
Mean (SD)
Mean (SD)
Mean (SD)

P-Value

Final Score

87.99 (22.08)

84.18 (25.43)

88.80 (21.20)

< 0.001

Quality Category
Score

83.35 (28.55)

78.15 (32.33)

84.47 (27.55)

< 0.001

PI Category Score

71.39 (43.98)

61.22 (47.29)

73.58 (42.92)

< 0.001

IA Category Score

38.52 (7.20)

37.93 (8.52)

38.65 (6.87)

< 0.001

Cost Category
Score

27.78 (39.35)

31.82 (42.03)

26.90 (38.69)

< 0.001
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Table . MIPS Score Performance Against Benchmarks
Nationally
All Providers
(n=882,493)
n (%)
Providers With Minimum Score
(0 points)
Providers Who Scored
Maximum Score (100 Points)
Low Performers (Scored
Between 0 to 14.99 Points)
High Performers (Scored
Between 15 and 69.99 Points)
Exceptional Performers (Scored
Between 70 and 100 Points)

Rural Providers Urban Providers
(n=115,826)
(n=766,667)
n (%)
n (%)

15,475 (1.75)

2,017 (1.74)

13,458 (1.76)

424,973 (48.16)

55,115 (47.58)

369,858 (48.24)

17,842 (2.02)

2,385 (2.06)

15,457 (2.02)

123,046 (13.94)

17,458 (15.07)

105,588 (13.77)

741,605 (84.04)

95,983 (82.87)

645,622 (84.21)

Southeastern US
All Providers
Rural Providers Urban Providers
(n=108,112)
(n=19,202)
(n=88,910)
n (%)
n (%)
n (%)
Providers With Minimum Score
(0 points)
Providers Who Scored
Maximum Score (100 Points)
Low Performers (Scored
Between 0 to 14.99 Points)
High Performers (Scored
Between 15 and 69.99 Points)
Exceptional Performers (Scored
Between 70 and 100 Points)

1,123 (1.04)

256 (1.33)

867 (0.98)

54,549 (50.46)

8,987 (46.80)

45,562 (51.25)

1,421 (1.31)

436 (2.27)

985 (1.11)

18,064 (16.71)

4,086 (21.28)

13,978 (15.72)

88,627 (81.98)

14,680 (76.45)

73,947 (83.17)

4.1.4 Findings in Payment Adjustments
Table 5 expresses the average final payment adjustments received across all MIPS
eligible clinicians in the US, among MIPS eligible clinicians in the Southeast, and among
providers who participated in the program within the Southeast. Across all three groups, the
average final payment adjustment received by rural providers was statistically significantly lower
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than the average payment adjustment received by urban providers within the same group
(P<0.001). Among all rural eligible clinicians and rural providers participating in MIPS in the
Southeast, the mean final payment adjustments were 1.11% and 1.20%, respectively (P<0.001).
This difference was even greater in the Southeast. Among all urban eligible clinicians and
eligible providers participating in MIPS in the Southeast, the mean final payment adjustments
were 1.26% and 1.32%, respectively (P<0.001).
As shown in Table 6, the final payment adjustments received by rural and urban
providers both nationally and in the Southeast ranged from -5.00% to 1.68%. When looking only
at providers who participated in the MIPS program in the Southeast, the minimum payment
adjustment received was lower for urban providers than it was for rural providers: - 3.33% and 2.18%, respectively. The maximum payment adjustment received by both urban and rural
participating providers in the Southeast was the same as the maximum payment adjustment
received by all eligible clinicians across the US as well as in the Southeast (1.68%).
Table 7 shows the distribution of rural and urban providers and the final payment
adjustments received, both nationally and in the Southeast. Although the percentage of providers
receiving the minimum and maximum payment adjustments were not drastically different among
rural versus urban providers across the US, the difference is more pronounced for providers in
the Southeast. A higher percentage of rural providers received the minimum payment adjustment
of -5%, as opposed to urban providers in the Southeast (1.33% and 0.98%, respectively). A lower
percentage of rural providers received the maximum payment adjustment of 1.68%, as opposed
to urban providers in the Southeast (46.87% and 51.30%, respectively).
Similarly, the difference in the distribution of providers in receiving a negative, neutral,
or positive payment adjustment was more pronounced in the Southeast. A higher percentage of
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rural providers received a negative payment adjustment when compared to urban providers in the
Southeast (2.27% and 1.11%, respectively). A lower percentage of rural providers received a
positive payment adjustment when compared to urban providers in the Southeast (95.93% and
98.24%, respectively).
Table . Average Payment Adjustments Received

All Providers
(n=882,493)
Mean (SD)
Payment Adjustment

1.19 (0.01)

Nationally
Rural Providers
(n=115,826)
Mean (SD)
1.17 (0.01)

Southeastern US
All Providers
Rural Providers
(n=108,112)
(n=19,202)
Mean (SD)
Mean (SD)
Payment Adjustment

1.23 (0.01)

1.11 (0.01)

Urban Providers
(n=766,667)
Mean (SD)

P-Value

1.19 (0.01)

< 0.001

Urban Providers
(n=88,910)
Mean (SD)

P-Value

1.26 (0.01)

< 0.001

Southeastern US (Participating Providers)
All Providers
Rural Providers Urban Providers
(n=106,989)
(n=18,946)
(n=88,043)
Mean (SD)
Mean (SD)
Mean (SD)
Payment Adjustment

1.30 (0.01)

1.20 (0.01)
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1.32 (0.01)

P-Value
< 0.001

Table . Minimum and Maximum Payment Adjustment Received
Nationally
Rural
Providers

Urban
Providers

Minimum Payment Adjustment Received

-5.00%

-5.00%

Maximum Payment Adjustment Received

1.68%

1.68%

Rural
Providers

Urban
Providers

Minimum Payment Adjustment Received

-5.00%

-5.00%

Maximum Payment Adjustment Received

1.68%

1.68%

Southeastern US

Southeastern US (Participating Providers)
Rural
Providers

Urban
Providers

Minimum Payment Adjustment Received

-2.18%

-3.33%

Maximum Payment Adjustment Received

1.68%

1.68%
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Table . Distribution of Payment Adjustments Received
Nationally
All Providers
(n=882,493)
n (%)
Providers Receiving Minimum
Payment Adjustment
Providers Receiving Maximum
Payment Adjustment
Providers Receiving Negative
Payment Adjustment
Providers Receiving Neutral
Payment Adjustment
Providers Receiving Positive
Payment Adjustment

Rural Providers Urban Providers
(n=115,826)
(n=766,667)
n (%)
n (%)

15,575 (1.76)

2,020 (1.74)

13,555 (1.77)

429,134 (48.63)

56,258 (48.57)

372,876 (48.46)

17,842 (2.02)

2,385 (2.06)

15,457 (2.02)

4,552 (0.52)

750 (0.65)

3,802 (0.50)

860,099 (97.46)

112,691 (97.29)

747,408 (97.49)

Southeastern US
All Providers
Rural Providers Urban Providers
(n=108,112)
(n=19,202)
(n=88,910)
n (%)
n (%)
n (%)
Providers Receiving Minimum
Payment Adjustment
Providers Receiving Maximum
Payment Adjustment
Providers Receiving Negative
Payment Adjustment
Providers Receiving Neutral
Payment Adjustment
Providers Receiving Positive
Payment Adjustment

1,123 (1.04)

256 (1.33)

867 (0.98)

54,607 (50.51)

9,000 (46.87)

45,607 (51.30)

1,421 (1.31)

436 (2.27)

985 (1.11)

922 (0.85)

345 (1.80)

577 (0.65)

105,769 (97.83)

18,421 (95.93)

87,348 (98.24)
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CHAPTER V DISCUSSION
5.1 Discussion of Results
In this retrospective descriptive cohort analysis of MIPS 2018 participation and
performance, rural providers in the Southeast generally scored lower, performed poorer, and
received lower payment adjustments than their urban counterparts in the Southeast. These
findings extend prior evidence, which demonstrated that value-based payment programs
disproportionately penalize rural providers and practices, nationally. These findings also have
major implications for the overall design of MIPS and corresponding planned program updates
by CMS, as well as for rural healthcare providers seeking financial success under Medicare.
5.1.1 MIPS Participation
CMS defines “eligible clinicians” as healthcare providers that meet the MIPS eligibility
thresholds, determined on clinician type, Medicare patient volume, and Medicare charges. For
the 2018 performance year, Medicare providers who billed more than $90,000 for Part B covered
professional services and saw more than 200 Part B patients were designated as eligible
clinicians and were included in the 2018 QPP PUF dataset (CMS, 2018). CMS defines an
eligible clinician as having participated in MIPS if the provider reported data or received a final
score greater than zero (QPP, 2020). The percentage of eligible clinicians who were designated
as “participated” was lower for rural providers than for urban providers, both nationally and in
the Southeast. While the difference in rural and urban participation rates was not statistically
significant nationally, this difference was significant when assessing Southeast providers.
Overall, the participation rates for both rural and urban eligible clinicians was high,
which is consistent with CMS’ claims of exceeding their goals for provider participation in MIPS
during the initial years of the program’s implementation (QPP, 2019). A participation rate of
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above 98% reflects a significant number of providers who are determined to be eligible for
MIPS, are successfully reporting data, and are actively choosing to participate in MIPS.
However, evaluating MIPS participation rates based on CMS’ definition may not accurately
reflect participation in the program. Because CMS allows various methods for collecting and
submitting MIPS data, some provider data may be reported inadvertently, and not necessarily as
a result of active decision making by providers. The MIPS scoring methodology also allows
providers to avoid scoring zero points by reporting a minimal amount of data in order to be
recorded as a MIPS participant. Providers also had the option to manually attest their results for
certain MIPS categories on CMS’ QPP web interface, which could lead to inaccurate reporting
of data.
For these reasons, CMS’ definition of participation does not reflect providers’ efforts to
report data or actively choose to participate in MIPS. A more accurate measure of participation
would be to assess whether providers actively chose to report data to the program, and to
determine participation based on data reported across all 4 categories for the full performance
year. This would allow a more meaningful analysis of difference participation rates of rural
providers versus urban providers, thus identifying providers who are experiencing barriers to
MIPS participation.
5.1.2 MIPS Participation Type
There were four participation options for the MIPS 2018 Performance Year (QPP, 2018).
MIPS eligible clinicians could participate in MIPS as an individual, a group practice, a virtual
group, or as a MIPS APM Entity. If participating as an individual, a provider’s final score and
payment adjustment is based on individual performance. A provider may participate in MIPS as
a member of a group with other providers that are practicing in the same organization. If
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participating in a group, a provider’s final score and payment adjustment is based on the
aggregated performance of all providers in the group. Solo practitioners and groups with fewer
than 10 providers may choose to participate as a virtual group, where a provider’s final score and
payment adjustment is based on the aggregate performance of all providers in the virtual group.
A MIPS APM Entity is defined as an entity that participates in an Alternative Payment Model or
other payer arrangement through a direct agreement with CMS. If participating in MIPS APM, a
provider’s final score and payment adjustment is based on the aggregate performance of all
providers in the MIPS APM (CMS, 2021d). Nationally, more rural and urban providers
participated in MIPS as a group than any other participation option. While more rural providers
participated in MIPS as a group in the Southeast, more urban providers participated as a MIPS
APM than any other participation option.
CMS allows eligible clinicians the choice in reporting to MIPS as an individual or
through one of the three group reporting options, depending on the provider’s practice
affiliations or practice size. The MIPS participation type impacts the measures and activities
reported and the reporting requirements, as well as the providers’ final scores and payment
adjustments. Reporting to MIPS as a group or by participating in a MIPS APM may have several
advantages, including distributing the administrative burden of reporting across multiple
providers and providing more flexibility in reporting quality measures. Conversely, reporting as
an individual may have drawbacks, including not having other providers’ performance to
supplement final scores or not being able to share the responsibility of meeting reporting
benchmarks for certain MIPS measures and activities (Hughes, 2020). This is also supported by
the findings of the current dissertation study, which revealed that both nationally and in the
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Southeast, the percentage of providers that reported as individuals was significantly higher for
rural providers than for urban providers.
Those current findings suggest that CMS should empirically assess how participation
type affects scoring and make the necessary program improvements to ensure that certain
providers aren’t disadvantaged based on the participation options available to them. Although the
individual reporting option may seem the least utilized, it is vital for CMS to continue to improve
this reporting option for providers who are not affiliated with a hospital or large practice and do
not have the option to report as a group or MIPS APM. This is particularly important for rural
providers, because solo and small practices are more likely to be located in rural areas (Liaw et
al., 2016). The CMS should also continue to improve the virtual group reporting option, which
was created to give solo practitioners and small practices the opportunity to join other eligible
clinicians and participate in MIPS as a group. This dissertation study found that no providers in
the MIPS 2018 Performance Year used the virtual group option to participate in the MIPS
program. The barriers to utilizing this reporting option should be identified and addressed for
future program years, especially for rural providers because this may be the only group
participation option applicable to them.
5.1.3 MIPS Final and Category Scores
Overall, rural providers performed considerably worse in MIPS 2018 than their urban
counterparts. On average, rural providers received a lower mean final score and mean category
score in all MIPS categories except cost than urban providers. Also, more rural providers
received the minimum final score possible (0 points) and were counted as “low performers”
(receiving a final score of less than 15 points). Similarly, fewer rural providers received the
maximum final score possible (100 points) or qualified as “exceptional providers” (receiving a
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final score of 70 points or higher). These findings are consistent with previous research
conducted nationally on the 2017 MIPS Performance Year; researchers determined that rural
providers performed considerably worse than their urban counterparts (Navathe, 2019). Those
findings are consistent with trends in rural participation in other Medicare quality reporting
programs, where small and rural physician practices disproportionally face challenges when
participating in Medicare’s legacy value-based care payment models (US GAO, 2016). Thus,
rural providers continue to be disadvantaged in participating in value-based programs that are
scored on performance, including MIPS.
Under CMS’ current scoring methodology for MIPS, certain categories are reweighted
when calculating final scores depending on the providers’ participation type. For the 2018
Performance Year, the Cost category was reweighted to 0% for all providers participating
through a MIPS APM (CMS, 2021d). This reweighting is reflected in the MIPS 2018 PUF by all
providers participating in a MIPS APM receiving a Cost category score of 0 points. While this
analysis showed rural providers in the Southeast had a higher mean score in the Cost category
than urban providers, the analysis also indicated more urban providers in the Southeast
participated through a MIPS APM. Because a score of 0 points based on MIPS APM
participation versus performance is not indicated in the PUF dataset, the mean cost scores do not
accurately reflect provider performance in this category. The higher mean score in the cost
category observed for rural providers is not reflecting better performance than urban providers.
Similarly to reweighting category scores based on participation type, CMS also awards
bonus points based on special statuses. For the MIPS 2018 Performance Year, rural designated
providers automatically received double the points for each Improvement Activity reported.
CMS’ intention of assigning special statuses and awarding bonus points is to give certain groups
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of eligible clinicians’ advantages in scoring to create a level playing field. However, these scores
are not differentiated in the PUF dataset. The mean score for the Improvement Activity category
was higher for urban providers than for rural providers. If CMS is creating special statuses and
bonus points to level the playing field and provide preferential scoring to disadvantaged provider
groups, MIPS data should be collected in a way that allows CMS to quantitatively assess whether
these points are having the desired impact on the final score, which is ultimately reflected in the
payment adjustment earned.
5.1.4 Payment Adjustments
On average, rural providers received a lower payment adjustment than urban providers,
particularly in Southeastern states. This study also determined the maximum positive payment
adjustment across all participants in 2018 was only 1.68%, an amount vastly lower than the 25%
increase possible under the program publicized by CMS. This is also lower than the amount
received during the MIPS 2017 Performance Year, where the maximum positive payment
adjustment received was 1.88% (Navathe et al., 2019). The maximum negative payment
adjustment received was consistent with CMS’ publicized amount at -5%, which was 1% lower
than the minimum adjustment received during the 2017 Performance Year due to planned CMS
program updates (Squitieri & Chung, 2017). This study found that the percentage of providers
who received the maximum negative payment adjustment was higher for rural providers than for
urban providers (1.74% and 1.77%, respectively). This difference is greater when looking
specifically at rural versus urban providers in the Southeast (1.33% and 0.98%, respectively).
Due to the scoring methodology for MIPS, the number of providers receiving the maximum
negative adjustment may reflect rural providers having a lower participation rate, since eligible
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clinicians who do not participate automatically receive the maximum negative payment
adjustment.
This study also found that the percentage of providers who received the maximum
positive payment adjustment was nearly identical for rural providers and urban providers
(48.57% and 48.46%, respectively). However, the percentage of providers who received the
maximum positive payment adjustment was lower for rural providers in the Southeast than for
urban providers (46.87% and 51.30%, respectively). The percentage of providers who received a
negative payment adjustment was higher for rural providers than for urban providers in the
Southeast, and the percentage of providers who received a positive adjustment was lower for
rural providers than for urban providers. These findings are consistent with results from other
studies that demonstrated proportionally more rural practices received negative payment
adjustments versus program participants overall in 2017 (Navathe et al., 2019). The findings
from the current study indicated that rural providers were financially disadvantaged in the MIPS
2018 Performance Year when compared to their urban counterparts, particularly in the Southeast.
5.2 Limitations
This analysis is limited to data that are provided by CMS in their Public Use File. One
limitation to evaluating provider performance in MIPS is that the data file does not include the
raw scores for individual measures and activities submitted, so analysis can only be completed at
a category level. Also, special statuses and bonus measures are not differentiated in the dataset,
which limits the ability to assess provider performance by taking into account bonus points and
reweighted category scores. This limitation also impacts the mean final scores and category
scores calculated in this analysis, as a more accurate analysis of provider performance would
take into account these special scoring mechanisms. An additional limitation is the method that
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CMS uses to define that a provider is participating in MIPS. A more accurate method of
assessing provider participation in this analysis would be to define participation as actively
choosing to submit data to MIPS. However, the participation variable would have to be redefined
on the PUF by CMS in order to allow for this to be measured.
5.3 Future Research
Available research on the impact of MIPS and its viability as a permanent physician
payment system is based mostly on qualitative data and conjecture from historical experiences;
limited research is available that provides empirical evaluations or utilizes quantitative data in its
findings. Additional research on MIPS participation and performance will be vital to the
program’s success, particularly with disadvantaged groups like rural healthcare providers. As
this analysis and previous studies conducted by other researchers have shown, programs like
MIPS appear to be disproportionately rewarding larger, urban practices with fewer socially atrisk patients, while penalizing smaller, rural practices that serve disadvantaged populations. As
CMS makes changes to the program during the next few years, barriers to participation and
reasons for lower scores should be empirically assessed using MIPS program data. CMS should
also consider improving the PUF for future Performance Years to allow more salient analyses of
MIPS participation and performance. This includes publishing raw performance data on
individual measures and activities submitted, geographic information on providers including city
and zip code, and the submission method used by participating providers. As the MIPS program
matures, future research will be vital to ensure that CMS is making the appropriate program
updates and awarding bonus points or assigning special statuses to disadvantaged providers to
allow for successful participation in the program.
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5.4 Conclusion
While rewarding provider performance based on quality is a laudable policy goal, rural
healthcare providers, particularly in the Southeast, continue to be disadvantaged under quality
reporting programs like MIPS. The results of this study indicate that rural providers had a lower
participation rate, scored lower performance points, and received lower payment adjustments
when compared to their urban counterparts. To ensure that rural healthcare providers are
successful under value-based payment systems like MIPS, it is urgent that policymakers continue
to improve MIPS in future program years, consider additional policy measures to ensure a level
playing field for rural and urban providers, and support additional research to identify barriers to
provider participation and performance. As this analysis has shown, MIPS needs to be
fundamentally reshaped for successful rural participation and performance, which is essential for
CMS to achieve their goal of creating a sustainable physician reimbursement model that controls
federal spending on healthcare.
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